cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Harrow Health Inc
1 watching
Current Price
$0
$1.02
(6.31%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
437.52M
52-Week High
52-Week High
17.84
52-Week Low
52-Week Low
5.4
Average Volume
Average Volume
0.34M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
45.2553
iconMarket Capitalization437.52M
icon52-Week High17.84
icon52-Week Low5.4
iconAverage Volume0.34M
iconDividend Yield--
iconP/E Ratio45.2553
What does the Harrow Health Inc do?
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Read More
How much money does Harrow Health Inc make?
News & Events about Harrow Health Inc.
Ticker Report
8days ago
Harrow Health (NASDAQ:HROW Get Rating) had its target price raised by research analysts at Lake Street Capital from $17.00 to $24.00 in a research note issued on Tuesday, The Fly reports. Lake Street Capitals target price points to a potential upside of 59.47% from the companys...
Business Wire
11days ago
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the closing of its previously announced acquisition of the exclusive U.S. commercial rights to five branded ophthalmic products: ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE. Pursuant to the terms of an asset...
Business Wire
1month ago
Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced top-line results of its Phase 2 pivotal efficacy and safety study for its lead product candidate, MELT-300, a sublingual, needle- and opioid-free patented...
Business Wire
1month ago
Harrow Health, Inc. (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic prescription therapies, today announced the pricing of its underwritten registered public offering of $35 million aggregate...
Business Wire
2 months ago
Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic prescription therapies, and iOR Partners, the pioneer in office-based surgery in the field of ophthalmology, today jointly announced the...
Frequently Asked Questions
Frequently Asked Questions
What is Harrow Health Inc share price today?
plus_minus_icon
Can Indians buy Harrow Health Inc shares?
plus_minus_icon
How can I buy Harrow Health Inc shares from India?
plus_minus_icon
Can Fractional shares of Harrow Health Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Harrow Health Inc stocks?
plus_minus_icon
What is today’s traded volume of Harrow Health Inc?
plus_minus_icon
What is today’s market capitalisation of Harrow Health Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Harrow Health Inc?
plus_minus_icon
What percentage is Harrow Health Inc down from its 52-Week High?
plus_minus_icon
What percentage is Harrow Health Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$1.02
(6.31%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00